A German medical device manufacturer will build a new 60,000-square-foot plant on its 35-acre site in Peachtree City, hiring 120 people and investing more than $10 million over the next year, Gov. Nathan Deal’s office announced Monday.
The expansion comes two decades after Gerresheimer Peachtree City LP set up its first operation in Georgia in 1993.
Gerresheimer, whose parent company has 40 plants all over the world, is to make more insulin pens, inhalers and other consumer-focused medical devices at the new facility, which will begin production in 2015 to meet increasing global demand.
About half of the state’s life science companies make medical devices, according to Chris Carr, commissioner of the Georgia Department of Economic Development.
The state has been on a push to position itself as a biotechnology hub as it seeks to attract more high-paying production jobs. Its biggest success to date is Baxter International, which is building a $1 billion plasma products plant in Covington east of Atlanta.
Two-thirds of the new production area for Gerresheimer will be comprised of clean rooms.
More information here.